ExAblate Receives Approval of Health Canada for the Treatment of Uterine Fibroids and Pain Palliation of Bone Metastases

ExAblate Receives Approval of Health Canada for the Treatment of Uterine Fibroids and Pain Palliation of Bone Metastases (via PR Newswire)

Third generation ExAblate system, using non-invasive MR guided Focused Ultrasound (MRgFUS) now available for Canadian patients TIRAT CARMEL, Israel, August 22, 2013 /PRNewswire/ — InSightec Ltd, the leader in MR guided Focused Ultrasound therapy, announced…